Protalix Biotherapeutics Inc (PLX)
Working Capital Ratio
55.13%
Quarterly · Period ending:
PLX Working Capital Ratio
Latest reported55.13%period ending
Latest reported55.13%period ending
PLX Quarterly Working Capital Ratio (100.00% → 55.13%)
Quarterly working capital ratio
High-resolution chart · PNG
PLX working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 55.1307% | |
| 57.622% | |
| 48.7638% | |
| 54.1634% | |
| 52.7406% | |
| 48.9796% | |
| 46.9333% | |
| 38.3883% | |
| 21.1875% | |
| 22.9068% | |
| 28.9007% | |
| 33.4125% | |
| 57.0784% | |
| 35.887% | |
| 22.3188% | |
| 20.2049% | |
| 30.9037% | |
| 31.0143% | |
| 38.6751% | |
| 34.0912% | |
| -0.2994% | |
| 9.5698% | |
| -45.266% | |
| 22.7313% | |
| 16.4482% | |
| 12.2339% | |
| -16.9545% | |
| 13.2517% | |
| 28.2484% | |
| 33.2629% | |
| 45.198% | |
| 63.6769% | |
| 54.0979% | |
| 52.7632% | |
| 55.2511% | |
| 40.2273% | |
| 50.4661% | |
| 57.4152% | |
| 6.8756% | |
| 69.9762% | |
| 71.2429% | |
| 76.7266% | |
| 76.7544% | |
| 42.0611% | |
| 42.983% | |
| 45.8514% | |
| 50.0956% | |
| 55.2202% | |
| 57.0972% | |
| 59.7393% | |
| 62.8299% | |
| 66.0091% | |
| 30.9826% | |
| 40.728% | |
| 44.9846% | |
| 50.5893% | |
| 52.854% | |
| 46.9049% | |
| 26.6345% | |
| 36.1144% | |
| 43.0016% | |
| 52.0544% | |
| 42.3767% | |
| 50.5057% | |
| 57.9052% | |
| 60.1226% | |
| 62.7135% | |
| 48.2529% | |
| 58.938% | |
| 68.3594% | |
| 74.5154% | |
| 79.7291% | |
| 82.4005% | |
| 84.576% | |
| 87.1846% | |
| 70.8798% | |
| 77.8103% | |
| 82.0542% | |
| 81.6029% | |
| 98.5493% | |
| 98.5744% | |
| 93.956% | |
| 92.6136% | |
| 87.6563% | |
| 89.0974% | |
| 87.4802% | |
| 87.5452% | |
| 89.5809% | |
| 89.4237% | |
| 91.0758% | |
| 89.2649% | |
| 91.7343% | |
| 92.2438% | |
| 90.4021% | |
| 86.0227% | |
| 87.4108% | |
| 87.57% | |
| 86.6021% | |
| 85.8938% | |
| 75.0674% |